The Body Covers: The First International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV
Joep Lange, M.D.
In 1984, Dr. Lange became involved in providing clinical guidance to the Amsterdam Cohort-Study of HIV Infection and AIDS. In 1985, he started laboratory investigations in the Human Retrovirus Laboratory of the University of Amsterdam, which led to his PhD thesis, "Serological Markers in HIV Infection."
Dr. Lange has served as director of the National AIDS Therapy Evaluation Centre (NATEC) since 1990, coordinating clinical trials in the field of HIV-infection and its secondary complications in about twenty Dutch hospitals caring for HIV-infected people.
From 1992 until 1995 ran such efforts on a global scale as a chief of the World Health Organization's Clinical Research and Product Development branch of the Global Programme on AIDS. Under Dr. Lange, the Research and Development unit worked to promote and initiate prevention, diagnosis and treatment projects throughout the world. Such projects continue in Argentina, Brazil, Ivory Coast, Mexico, Tanzania, Thailand, Uganda, Uruguay, and Venezuela.
In January of 1995, Dr. Lange returned to his alma mater, the University of Amsterdam, to take up the position he currently holds as a professor of Internal Medicine, researching and teaching about viral diseases in particular.
This article was provided by The Body PRO. Copyright © Body Health Resources Corporation. All rights reserved.